Evaluation of a new transperineal ultrasound probe for inter-fraction image-guidance for definitive and post-operative prostate cancer radiotherapy

PURPOSE - The aim of this study was to evaluate a new system based on transperineal ultrasound (TP-US) acquisitions for prostate and post-prostatectomy pre-treatment positioning by comparing this device to cone-beam computed tomography (CBCT).

METHODS - The differences between CBCT/CT and TP-US/TP-US registrations were analyzed on 427 and 453 sessions for 13 prostate and 14 post-prostatectomy patients, respectively. The inter-operator variability (IOV) of the registration process, and the impact and variability of the probe pressure were also evaluated.

RESULTS - CBCT and TP-US shift agreements at ± 5 mm were 76. 6%, 95. 1%, 96. 3% and 90. 3%, 85. 0%, 97. 6% in anterior-posterior, superior-inferior and left-right directions, for prostate and post-prostatectomy patients, respectively. IOV values were similar between the 2 modalities. Displacements above 5 mm due to strong pressures were observed on both localizations, but such pressures were rarely reproduced during treatment courses.

CONCLUSIONS - High concordance between CBCT/CT and TP-US/TP-US localization of prostates or prostatic beds was found in this study. TP-US based prepositioning is a feasible method to ensure accurate treatment delivery, and represents an attractive alternative to invasive and/or irradiating imaging modalities.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). 2016 Feb 02 [Epub ahead of print]

Marie Fargier-Voiron, Benoît Presles, Pascal Pommier, Alexandre Munoz, Simon Rit, David Sarrut, Marie-Claude Biston

CREATIS, INSA, Université de Lyon, CNRS UMR5220, Inserm U1044, Lyon F-69622, France. , CREATIS, INSA, Université de Lyon, CNRS UMR5220, Inserm U1044, Lyon F-69622, France. , Léon Bérard Cancer Center, University of Lyon, Lyon F-69373, France. , Léon Bérard Cancer Center, University of Lyon, Lyon F-69373, France. , CREATIS, INSA, Université de Lyon, CNRS UMR5220, Inserm U1044, Lyon F-69622, France. , CREATIS, INSA, Université de Lyon, CNRS UMR5220, Inserm U1044, Lyon F-69622, France; Léon Bérard Cancer Center, University of Lyon, Lyon F-69373, France. , CREATIS, INSA, Université de Lyon, CNRS UMR5220, Inserm U1044, Lyon F-69622, France; Léon Bérard Cancer Center, University of Lyon, Lyon F-69373, France. 

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe